ClinConnect ClinConnect Logo
Search / Trial NCT06328920

Intermittent Oro-esophageal Tube on Rehabilitation Therapy Compliance for Stroke

Launched by COPKA SONPASHAN · Mar 18, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how well stroke patients can stick to their rehabilitation therapy when they receive nutrition through two different methods. Some patients will get their nutrition through an Intermittent Oro-esophageal Tube, while others will use a Nasogastric Tube. The goal is to see which method helps patients adhere better to their rehabilitation program, which is important for their recovery after a stroke.

To participate in this trial, you need to be at least 18 years old and have been diagnosed with a stroke. You should also have some difficulty swallowing, called dysphagia, and be stable enough to cooperate with assessments. However, if you have other serious health issues or certain complications, you may not be eligible. If you join the study, you can expect to receive standard rehabilitation treatment alongside the nutrition method assigned to you, while researchers monitor how well you follow the rehabilitation program. The trial is not yet recruiting participants, so the start date is still to be determined.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age ≥ 18 years;
  • meeting the diagnostic criteria of stroke;
  • any degree of dysphagia at admission;
  • steady vital signs, without severe cognitive impairment or sensory aphasia, able to cooperate with the assessment.
  • transferred out within three weeks of hospitalization in the neurology department.
  • Exclusion Criteria:
  • complicated with other neurological diseases;
  • damaged mucosa or incomplete structure in nasopharynx;
  • tracheostomy tube plugged;
  • unfeasible to the support of parenteral nutrition;
  • simultaneously suffering from liver, kidney failure, tumors, or hematological diseases.

About Copka Sonpashan

Copka Sonpashan is a leading clinical trial sponsor dedicated to advancing innovative therapeutic solutions through rigorous research and development. With a focus on enhancing patient care, the organization specializes in designing and executing clinical trials across various therapeutic areas, ensuring compliance with regulatory standards and ethical guidelines. By fostering collaboration with healthcare professionals and leveraging cutting-edge technologies, Copka Sonpashan aims to expedite the drug development process while maintaining a steadfast commitment to patient safety and scientific integrity.

Locations

Patients applied

0 patients applied

Trial Officials

Nieto Luis

Study Chair

Site Coordinator of United Medical Group

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported